SCHEMBL25387140

SCHEMBL25387140

CC(C)(C)c1ccc(-c2cc(O)cc(O)c2)c(C(C)(C)C)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.44
ALOX15 P16050 3/20 0.44
HSD17B10 Q99714 3/20 0.44
HPGD P15428 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
LMNA P02545 2/20 0.43
TYR P14679 2/20 0.43
GABRA1 P14867 1/20 0.43
GABRB2 P47870 1/20 0.43
MAPT P10636 3/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 1/20 0.40
PKM P14618 1/20 0.40
RECQL P46063 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
NR1I2 O75469 1/20 0.38
CYP2C9 P11712 1/20 0.38
MIF P14174 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25387804 0.89 CNR1 (0.46) ALDH1A1ALOX15HSD17B10HPGDTDP1
SCHEMBL28147029 0.85 LMNA (0.54) ALDH1A1ALOX15HSD17B10HPGDTDP1
SCHEMBL8708320 0.84 HSD17B1 (0.42) ALDH1A1ALOX15HSD17B10HPGDTDP1
SCHEMBL30496142 0.80 KIF11 (0.43) ALDH1A1ALOX15HSD17B10HPGDTDP1
SCHEMBL2357462 0.80 ALDH1A1 (0.48) ALDH1A1ALOX15HSD17B10HPGDTDP1
SCHEMBL29763177 0.80 ALDH1A1 (0.48) ALDH1A1ALOX15HSD17B10HPGDTDP1
SCHEMBL7080577 0.79 ALDH1A1 (0.55) ALDH1A1ALOX15HSD17B10HPGDTDP1
SCHEMBL27193588 0.78 CNR1 (0.47) ALDH1A1ALOX15HSD17B10HPGDTDP1
Paraben SCHEMBL8429174 0.76 RXRB (0.57) ALOX15HSD17B10TDP1TYRMAPT
SCHEMBL29320313 0.74 CES2 (0.46) GAACYP2C9ABL1ABCB1BCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12598915-B2 Condensed cyclic compound, light-emitting device including the condensed cyclic compound, and electronic apparatus including the light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2026-04-07 US disclosed
CN-116574116-A Condensed cyclic compound, light-emitting device including the same, and electronic device 三星显示有限公司 2023-08-11 CN disclosed
US-20230255100-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-10 US disclosed
US-20230255100-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-10 US disclosed
US-20230255100-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12598915-B2 Condensed cyclic compound, light-emitting device including the condensed cyclic compound, and electronic apparatus including the light-emitting device RFC1, CRY1, SCO2 ALDH1A1 609/4885ALOX15 2558/4885HSD17B10 1789/4885
US-20230255100-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CCNE2, NCAPH ALDH1A1 443/4885ALOX15 1957/4885HSD17B10 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.